Overview

Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial

Status:
Completed
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
This is a phase I/II open-label study to determine the lowest, safe, effective dose of budesonide given with calfactant as the vehicle.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Cynthia McEvoy
Collaborators:
Florida Hospital for Children
Thrasher Research Fund
University of California, San Francisco
University of Florida
Treatments:
Budesonide
Calfactant
Pulmonary Surfactants